Related Experiment Videos
LncRNA PLCD3-OT1 Functions as a CeRNA to Prevent Age-Related Cataract by Sponging miR-224-5p and Regulating PLCD3
Jing Xiang1,2, Qin Chen3, Lihua Kang1
1Eye Institute, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China.
Purpose:
Long noncoding RNAs (lncRNAs) are important in disease progression and cellular functions. This study aimed to conduct global lncRNA profiling and characterize the role of lncRNA 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta 3-sence RNA 1 (PLCD3-OT1) in the progression of age-related cataract (ARC).
Methods:
We performed lncRNA expression profiling of lens capsule from ARC groups and age-matched groups using high-throughput RNA-sequencing. Real-time PCR was conducted to detect the expression pattern of lncRNA and mRNA in the clinical samples and cell model. Assays of cell-counting kit-8, 5'-ethynyl-2'-deoxyuridine, TUNEL, and propidium iodide staining were used to detect cell viability, proliferation, apoptosis, and cell cycle. We also performed fluorescence in situ hybridization assay to detect the location of lncRNA, and verified the endogenous competitive RNA mechanism between miRNAs, lncRNAs, and target genes via double-luciferase reporter analyses.
Results:
The expression of lncRNA PLCD3-OT1 and PLCD3 were significantly decreased in ARC. PLCD3-OT1 overexpression promoted the expression of PLCD3, cell viability, proliferation, and inhibited cell apoptosis upon oxidative stress, while knockdown of PLCD3 showed the opposite results. Mechanistically, PLCD3-OT1functions through positively regulation the expression of PLCD3. In addition, PLCD3-OT1 may act as a ceRNA to regulate the expression of PLCD3 through competition for miR-224-5p.
Conclusions:
PLCD3-OT1 and PLCD3 may become potential therapeutic targets for the prognosis, diagnosis, and treatment of ARC.
Insights
Long noncoding RNA PLCD3-OT1 is decreased in age-related cataract (ARC). Its overexpression promotes cell viability and proliferation, suggesting PLCD3-OT1 and PLCD3 as potential therapeutic targets for ARC.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) play critical roles in cellular functions and disease progression.
- Age-related cataract (ARC) is a leading cause of vision impairment globally.
- Understanding the molecular mechanisms underlying ARC is crucial for developing effective treatments.
Purpose of the Study:
- To perform global lncRNA profiling in age-related cataract (ARC).
- To investigate the role of lncRNA 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta 3-sence RNA 1 (PLCD3-OT1) in ARC progression.
Main Methods:
- High-throughput RNA-sequencing for lncRNA expression profiling in lens capsule samples.
- Real-time PCR to validate lncRNA and mRNA expression in clinical samples and cell models.
- Cellular assays (CCK-8, EdU, TUNEL, PI staining) to assess cell viability, proliferation, and apoptosis.
Main Results:
- lncRNA PLCD3-OT1 and its target gene PLCD3 expression were significantly decreased in ARC.
- Overexpression of PLCD3-OT1 enhanced cell viability, proliferation, and inhibited apoptosis under oxidative stress.
- PLCD3-OT1 positively regulates PLCD3 expression, potentially acting as a competing endogenous RNA (ceRNA) for miR-224-5p.
Conclusions:
- PLCD3-OT1 plays a protective role in age-related cataract progression.
- PLCD3-OT1 and PLCD3 represent potential therapeutic targets for ARC diagnosis and treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Regulation of Nuclear Protein Sorting
Negative Regulator Molecules